Antibody Therapy Market Size

Antibody Therapy Market Size

Antibody Therapy Market size accounted for USD 214.7 billion in 2022 and is projected to expand at 11.8% CAGR from 2023 to 2032. The industry is experiencing exponential growth from the last few years as new therapies and drugs have been approved for the treatment of diseases. To date, the Food and Drug Administration (FDA) has approved more than 100 antibody products and every year around a fifth of new drug approvals are of biologics. The presence of a healthy antibody therapy pipeline creates a high potential for the company to attain larger market revenue.

To get key market trends

  Download Free Sample

Antibody therapy is a targeted therapeutic intervention comprising concentrated or monoclonal antibody used to manage diseases such as cancer/oncology, infectious diseases and autoimmune diseases among other diseases. These therapeutic antibodies bind to specific molecules on the surface of cells, triggering immune responses that help eliminate or inhibit the growth of abnormal cells. This precise targeting makes antibody therapy a promising approach for treating various diseases, offering a tailored and effective strategy in the field of medical intervention and personalized medicine.